L. Bastian

发表

In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets

Johannes W. Bagnoli, B. Vick, I. Jeremias, 2020, Nature Communications.

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.

H. Jäck, A. Nist, T. Stiewe, 2022, Cell death and differentiation.

An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse

Michael P. Schroeder, M. P. Schroeder, M. Schrappe, 2022, BMC Genomic Data.

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

B. Vick, I. Jeremias, C. Eckert, 2021, Blood advances.

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

Michael P. Schroeder, H. Blum, M. P. Schroeder, 2019, Leukemia.

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Oscar Arturo Migueles Lozano, Michael P. Schroeder, M. P. Schroeder, 2019, Scientific Reports.

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab

R. Burger, M. Peipp, J. Leusen, 2022, Frontiers in Immunology.

FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling

Michael P. Schroeder, M. P. Schroeder, M. Neumann, 2023, Scientific Reports.

Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL

K. Spiekermann, U. Kees, M. Neumann, 2016, Journal of Hematology & Oncology.

Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia

Michael P. Schroeder, M. P. Schroeder, A. Akalin, 2018, bioRxiv.

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

H. Jäck, T. Stiewe, M. Buchholz, 2022, bioRxiv.

High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse

C. Eckert, G. Henze, K. Seeger, 2011, Haematologica.

Clinical and Cytogenetic Characteristics of Children With Leukemia 20-Year Retrospective Study

B. Lozić, M. Lozić, A. Jeličić Kadić, 2022, Journal of pediatric hematology/oncology.

CLINICAL AND CYTOGENETIC FEATURES OF LEUKEMIAS IN CHILDREN TREATED IN THE UNIVERSITY HOSPITAL OF SPLIT FROM 2000

L. Bastian, 2018 .

Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)

M. Spielmann, S. Hänzelmann, S. Xia, 2022, Leukemia.

Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB

C. Eckert, I. Fichtner, G. Henze, 2013, Clinical Cancer Research.

Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.

M. Schrappe, C. Eckert, A. Kulozik, 2022, Blood.

The gene expression classifier ALLCatchR identifies B-precursor ALL subtypes and underlying developmental trajectories across age

C. Kaleta, M. Schrappe, J. Kässens, 2023, bioRxiv.

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

M. Spielmann, K. Döhner, H. Busch, 2022, Leukemia.

of p 53 , PI 3 K / AKT , and NF-of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation Synergistic Activity of Bortezomib and HDACi in Preclinical Models

C. Eckert, I. Fichtner, K. Seeger, 2013 .

Cancer Therapy : Preclinical Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p 53 , PI 3 K / AKT , and NFk B

C. Eckert, I. Fichtner, K. Seeger, 2013 .

Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications

N. Darzentas, M. Szczepanowski, C. Baldus, 2023, Frontiers in Immunology.

IGH Rearrangement Evolution in Adult KMT2A-rearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring

N. Darzentas, M. Szczepanowski, M. Neumann, 2022, HemaSphere.

CLINICAL AND CYTOGENETIC FEATURES OF LEUKEMIAS IN CHILDREN TREATED IN THE UNIVERSITY HOSPITAL OF SPLIT FROM 2000 TO 2017

L. Bastian, 2018 .

Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer

O. Janssen, D. Bauerschlag, F. Theilig, 2023, Journal of extracellular vesicles.

Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells

J. Andersen, R. Burger, Stian Foss, 2023, Frontiers in Immunology.

PS942 CD19 MUTATION FREQUENCY AFTER BLINATUMOMAB TREATMENT IS LOWER THAN AFTER CAR T-CELLS TREATMENT

M. P. Schroeder, N. Darzentas, A. Franke, 2019, HemaSphere.

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Oscar Arturo Migueles Lozano, Michael P. Schroeder, J. Wolf, 2019, Scientific Reports.

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age

C. Kaleta, M. Schrappe, J. Kässens, 2023, HemaSphere.

AP-1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL

A. Borkhardt, M. Schrappe, A. Alsadeq, 2023, HemaSphere.

Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB

C. Eckert, I. Fichtner, G. Henze, 2013, Clinical Cancer Research.

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

Michael P. Schroeder, H. Blum, P. Greif, 2019, Leukemia.

Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL

C. Haferlach, M. Stelljes, W. Walter, 2023, Blood.

An alternative

Michael P. Schroeder, M. Schrappe, C. Eckert, 2022 .

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

P. Greif, S. Raffel, H. Trautmann, 2024, Leukemia.